Status:

COMPLETED

Cryotechnique as a Diagnostic and Therapeutic Tool of Endobronchial Tumors

Lead Sponsor:

Sohag University

Collaborating Sponsors:

Cairo University

Conditions:

Cryotherapy Effect

Bronchial Neoplasms

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study was to assess the diagnostic yield and the safety of bronchoscopic cryotechniques in the management of endobronchial tumors.

Detailed Description

Novel flexible cryoprobes were introduced for tissue sampling during bronchoscopy. Employing this approach, the sample is collected when frozen, with the tissue attached to the frozen end of the probe...

Eligibility Criteria

Inclusion

  • patients with radiologically suspected endobronchial masses

Exclusion

  • Patients with contraindications to bronchoscopy.
  • uncorrected coagulopathy (if the international normalized ratio (INR) is more than 1.5).
  • severe refractory hypoxemia (even after administering the highest possible dose of oxygen, the partial pressure of oxygen ("PaO2") stays below 70 mm Hg.
  • hypoventilation with hypercapnia (type 2 respiratory failure).
  • severe pulmonary hypertension \> 55 mmHg by echocardiography.
  • hemodynamic instability.

Key Trial Info

Start Date :

July 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 30 2022

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT06531265

Start Date

July 1 2019

End Date

October 30 2022

Last Update

July 31 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Sohag University

Sohag, Egypt, 82425

2

Sohag University

Sohag, Egypt, 82524